Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a large decrease in short interest in December. As of December 15th, there was short interest totalling 39,900 shares, a decrease of 19.9% from the November 30th total of 49,800 shares. Based on an average daily volume of 34,600 shares, the short-interest ratio is presently 1.2 days.

Ocean Biomedical Price Performance

Shares of OCEAW stock traded up $0.00 during trading hours on Friday, reaching $0.03. The company had a trading volume of 17,969 shares, compared to its average volume of 40,811. Ocean Biomedical has a twelve month low of $0.02 and a twelve month high of $0.70. The stock’s fifty day simple moving average is $0.04 and its 200 day simple moving average is $0.04.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.